RATIONALE: Infliximab may help improve energy levels in patients who have undergone treatment for breast cancer.||PURPOSE: This phase II trial is studying how well infliximab works in treating cancer-related fatigue in postmenopausal women who have undergone treatment for stage 0, stage I, or stage II breast cancer.